Skip to main content
Top
Published in: Rheumatology International 11/2012

01-11-2012 | Original Article

Evaluating hand in systemic sclerosis

Authors: Didem Arslan Tas, Eren Erken, Hakan Sakalli, A. Eftal Yucel

Published in: Rheumatology International | Issue 11/2012

Login to get access

Abstract

Articular symptoms are common in SSc and joint pain is a frequent presenting feature of this disease. Hand involvement is often the first clinical manifestation of SSc and could be resulted from fibrosis or synovitis or an overlap syndrome with rheumatoid arthritis (RA); though, the latter is a controversy in practice. To define the clues when identifying the nature of the hand arthropathy in SSc. In order to determine the hand arthropathy, serological tests, hand radiography, finger-to-palm (FTP) distance and other clinical features, disease activity and functional scoring parameters were assessed. Twenty-eight consecutive SSc patients and 43 controls (21 rheumatoid arthritis and 22 healthy controls) were included. Radiographic findings in SSc patients were: Erosions 25%, joint space narrowing 17.9%, arthritis 10.7%, radiological demineralisation 42.9%, acro-osteolysis 25%, flexion contracture 28.6% and calcinosis 17.9%. Anti-CCP antibody and RF positivity were as follows: In SSc group: 3 (11%) and 7 patients (25%); In RA group: 13 (62%) and 19 patients (90.5%); In healthy control group: 1 (4%) and 3 persons (13.6%), respectively. Two patients (7.14%) were regarded as RA overlap, whom both had positive RF and positive anti-CCP results and their radiographs revealed arthritis. Seventeen patients (61%) were regarded as SSc arthropathy; all were negative for RF and anti-CCP but revealed nonarthritic radiological findings. (Among them, only one patient had positive anti-CCP result). The remainder (9 patients) had no radiological or serological finding positive for arthropathy. Arthritis was found to have correlation with heart involvement and FTP was correlated with lung involvement. Hand involvement in SSc is a challenge in rheumatology practice; Radiographic testing when evaluated with RF and anti-CCP will be a helpful tool to discriminate SSc arthropathy from RA-SSc overlap. Hand arthropathy should increase the interest in the serious internal organ involvements of SSc.
Literature
1.
go back to reference Zimmermann C, Steiner G, Skriner K, Hassfeld W, Petera P, Smolen JS (1998) The concurrence of rheumatoid arthritis and limited systemic sclerosis: clinical and serologic characteristics of an overlap syndrome. Arthritis Rheum 41(11):1938–1945PubMedCrossRef Zimmermann C, Steiner G, Skriner K, Hassfeld W, Petera P, Smolen JS (1998) The concurrence of rheumatoid arthritis and limited systemic sclerosis: clinical and serologic characteristics of an overlap syndrome. Arthritis Rheum 41(11):1938–1945PubMedCrossRef
2.
go back to reference Sandqvist G, Hesselstrand R, Eberhardt K (2009) A longitudinal follow-up of hand involvement and activities of daily living in early systemic sclerosis. Scand J Rheumatol 38(4):304–310PubMedCrossRef Sandqvist G, Hesselstrand R, Eberhardt K (2009) A longitudinal follow-up of hand involvement and activities of daily living in early systemic sclerosis. Scand J Rheumatol 38(4):304–310PubMedCrossRef
3.
go back to reference Arslan Tas D (1980) Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23(5):581–590 Arslan Tas D (1980) Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23(5):581–590
4.
go back to reference LeRoy EC, Black C, Fleischmajer R et al (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15:202–205PubMed LeRoy EC, Black C, Fleischmajer R et al (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15:202–205PubMed
5.
go back to reference McHugh NJ, Distler O, Giacomelli R, Riemekasten G (2003) Non organ based laboratory markers in systemic sclerosis. Clin Exp Rheumatol 21(3 Suppl 29):S32–S38PubMed McHugh NJ, Distler O, Giacomelli R, Riemekasten G (2003) Non organ based laboratory markers in systemic sclerosis. Clin Exp Rheumatol 21(3 Suppl 29):S32–S38PubMed
6.
go back to reference Avouac J, Guerini H, Wipff J, Assous N, Chevrot A, Kahan A, Allanore Y (2006) Radiological hand involvement in systemic sclerosis. Ann Rheum Dis 65(8):1088–1092PubMedCrossRef Avouac J, Guerini H, Wipff J, Assous N, Chevrot A, Kahan A, Allanore Y (2006) Radiological hand involvement in systemic sclerosis. Ann Rheum Dis 65(8):1088–1092PubMedCrossRef
7.
go back to reference Akesson A, Fiori G, Krieg T et al (2003) Assessment of skin, joint, tendon and muscle involvement. Clin Exp Rheumatol 29 (Suppl):S5e8 Akesson A, Fiori G, Krieg T et al (2003) Assessment of skin, joint, tendon and muscle involvement. Clin Exp Rheumatol 29 (Suppl):S5e8
8.
go back to reference Kahaleh B, Meyer O, Scorza R (2003) Assessment of vascular involvement. Clin Exp Rheumatol 29(Suppl 29):S9e14 Kahaleh B, Meyer O, Scorza R (2003) Assessment of vascular involvement. Clin Exp Rheumatol 29(Suppl 29):S9e14
9.
go back to reference Clements PJ, Becvar R, Drosos AA et al (2003) Assessment of gastrointestinal involvement. Clin Exp Rheumatol 29(Suppl):S15e8 Clements PJ, Becvar R, Drosos AA et al (2003) Assessment of gastrointestinal involvement. Clin Exp Rheumatol 29(Suppl):S15e8
10.
go back to reference Matucci-Cerinic M, D’Angelo S, Denton CP et al (2003) Assessment of lung involvement. Clin Exp Rheumatol 29(Suppl):S19e23 Matucci-Cerinic M, D’Angelo S, Denton CP et al (2003) Assessment of lung involvement. Clin Exp Rheumatol 29(Suppl):S19e23
11.
go back to reference Ferri C, Emdin M, Nielsen H et al (2003) Assessment of heart involvement. Clin Exp Rheumatol 29(Suppl):S24e8 Ferri C, Emdin M, Nielsen H et al (2003) Assessment of heart involvement. Clin Exp Rheumatol 29(Suppl):S24e8
12.
go back to reference Steen VD, Mayes MD, Merkel PA (2003) Assessment of kidney involvement. Clin Exp Rheumatol 29(Suppl):S29e32 Steen VD, Mayes MD, Merkel PA (2003) Assessment of kidney involvement. Clin Exp Rheumatol 29(Suppl):S29e32
13.
go back to reference Clements P, Lachenbruch P, Siebold J, White B, Weiner S, Martin R, Weinstein A, Weisman M, Mayes M, Collier D et al (1995) Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol 22(7):1281–1285PubMed Clements P, Lachenbruch P, Siebold J, White B, Weiner S, Martin R, Weinstein A, Weisman M, Mayes M, Collier D et al (1995) Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol 22(7):1281–1285PubMed
14.
go back to reference Valentini G, Della Rossa A, Bombardieri S et al (2001) European multicentre study to define disease activity criteria for systemic sclerosis. II. Identification of disease activity variables and development of preliminary activity indexes. Ann Rheum Dis 60(6):592–598PubMedCrossRef Valentini G, Della Rossa A, Bombardieri S et al (2001) European multicentre study to define disease activity criteria for systemic sclerosis. II. Identification of disease activity variables and development of preliminary activity indexes. Ann Rheum Dis 60(6):592–598PubMedCrossRef
15.
go back to reference Silman A, Akesson A, Newman J et al (1998) Assessment of functional ability in patients with scleroderma: a proposed new disability assessment instrument. J Rheumatol 25:79–83PubMed Silman A, Akesson A, Newman J et al (1998) Assessment of functional ability in patients with scleroderma: a proposed new disability assessment instrument. J Rheumatol 25:79–83PubMed
16.
go back to reference Blocka KL, Bassett LW, Furst DE, Clements PJ, Paulus HE (1981) The arthropathy of advanced progressive systemic sclerosis A radiographic survey. Arthritis Rheum 24(7):874–884PubMedCrossRef Blocka KL, Bassett LW, Furst DE, Clements PJ, Paulus HE (1981) The arthropathy of advanced progressive systemic sclerosis A radiographic survey. Arthritis Rheum 24(7):874–884PubMedCrossRef
17.
go back to reference Misra R, Darton K, Jewkes RF, Black CM, Maini RN (1995) Arthritis in scleroderma. Br J Rheumatol 34(9):831–837PubMedCrossRef Misra R, Darton K, Jewkes RF, Black CM, Maini RN (1995) Arthritis in scleroderma. Br J Rheumatol 34(9):831–837PubMedCrossRef
18.
go back to reference Baron M, Lee P, Keystone EC (1982) The articular manifestations of progressive systemic sclerosis (scleroderma). Ann Rheum Dis 41(2):147–152PubMedCrossRef Baron M, Lee P, Keystone EC (1982) The articular manifestations of progressive systemic sclerosis (scleroderma). Ann Rheum Dis 41(2):147–152PubMedCrossRef
19.
go back to reference Erre GL, Marongiu A, Fenu P, Faedda R, Masala A, Sanna M, Soro G, Tocco A, Piu D, Marotto D, Passiu G (2008) The “sclerodermic hand”: a radiological and clinical study. Joint Bone Spine 75(4):426–431PubMedCrossRef Erre GL, Marongiu A, Fenu P, Faedda R, Masala A, Sanna M, Soro G, Tocco A, Piu D, Marotto D, Passiu G (2008) The “sclerodermic hand”: a radiological and clinical study. Joint Bone Spine 75(4):426–431PubMedCrossRef
20.
go back to reference La Montagna G, Sodano A, Capurro V, Malesci D, Valentini G (2005) The arthropathy of systemic sclerosis: a 12 month prospective clinical and imaging study. Skeletal Radiol 34(1):35–41PubMedCrossRef La Montagna G, Sodano A, Capurro V, Malesci D, Valentini G (2005) The arthropathy of systemic sclerosis: a 12 month prospective clinical and imaging study. Skeletal Radiol 34(1):35–41PubMedCrossRef
21.
go back to reference Takasaki Y, Yamanaka K, Takasaki C, Matsushita M, Yamada H, Nawata M, Matsudaira R, Ikeda K, Kaneda K, Hashimoto H (2004) Anticyclic citrullinated peptide antibodies in patients with mixed connective tissue disease. Mod Rheumatol 14(5):367–375PubMedCrossRef Takasaki Y, Yamanaka K, Takasaki C, Matsushita M, Yamada H, Nawata M, Matsudaira R, Ikeda K, Kaneda K, Hashimoto H (2004) Anticyclic citrullinated peptide antibodies in patients with mixed connective tissue disease. Mod Rheumatol 14(5):367–375PubMedCrossRef
22.
go back to reference van Paassen P, Damoiseaux J, Tervaert JW (2003) Laboratory assessment in musculoskeletal disorders. Best Pract Res Clin Rheumatol 17(3):475–494PubMedCrossRef van Paassen P, Damoiseaux J, Tervaert JW (2003) Laboratory assessment in musculoskeletal disorders. Best Pract Res Clin Rheumatol 17(3):475–494PubMedCrossRef
23.
go back to reference Ingegnoli F, Galbiati V, Zeni S, Meani L, Zahalkova L, Lubatti C, Soldi A, Paresce E, Murgo A, Crapanzano C, Fantini F (2007) Use of antibodies recognizing cyclic citrullinated peptide in the differential diagnosis of joint involvement in systemic sclerosis. Clin Rheumatol 26(4):510–514PubMedCrossRef Ingegnoli F, Galbiati V, Zeni S, Meani L, Zahalkova L, Lubatti C, Soldi A, Paresce E, Murgo A, Crapanzano C, Fantini F (2007) Use of antibodies recognizing cyclic citrullinated peptide in the differential diagnosis of joint involvement in systemic sclerosis. Clin Rheumatol 26(4):510–514PubMedCrossRef
24.
go back to reference Clements PJ, Seibold JR, Furst DE, Mayes M, White B, Wigley F, Weisman MD, Barr W, Moreland L, Medsger TA Jr, Steen V, Martin RW, Collier D, Weinstein A, Lally E, Varga J, Weiner SR, Andrews B, Abeles M, Wong WK (2004) High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial: lessons learned. Semin Arthritis Rheum 33(4):249–263PubMedCrossRef Clements PJ, Seibold JR, Furst DE, Mayes M, White B, Wigley F, Weisman MD, Barr W, Moreland L, Medsger TA Jr, Steen V, Martin RW, Collier D, Weinstein A, Lally E, Varga J, Weiner SR, Andrews B, Abeles M, Wong WK (2004) High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial: lessons learned. Semin Arthritis Rheum 33(4):249–263PubMedCrossRef
25.
go back to reference Ashida R, Ihn H, Mimura Y, Jinnin M, Asano Y, Kubo M, Tamaki K (2007) Clinical features of scleroderma patients with contracture of phalanges. Clin Rheumatol 26(8):1275–1277PubMedCrossRef Ashida R, Ihn H, Mimura Y, Jinnin M, Asano Y, Kubo M, Tamaki K (2007) Clinical features of scleroderma patients with contracture of phalanges. Clin Rheumatol 26(8):1275–1277PubMedCrossRef
26.
go back to reference Ingegnoli F, Boracchi P, Ambrogi F, Gualtierotti R, Galbiati V, Meroni PL (2010) Hand impairment in systemic sclerosis: association of different hand indices with organ involvement. Scand J Rheumatol 39(5):393–397PubMedCrossRef Ingegnoli F, Boracchi P, Ambrogi F, Gualtierotti R, Galbiati V, Meroni PL (2010) Hand impairment in systemic sclerosis: association of different hand indices with organ involvement. Scand J Rheumatol 39(5):393–397PubMedCrossRef
Metadata
Title
Evaluating hand in systemic sclerosis
Authors
Didem Arslan Tas
Eren Erken
Hakan Sakalli
A. Eftal Yucel
Publication date
01-11-2012
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 11/2012
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-011-2205-3

Other articles of this Issue 11/2012

Rheumatology International 11/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.